BWAY Stock Analysis: Buy, Sell, or Hold?
BWAY - Brainsway Ltd. American Depositary Shares
$16.32
0.01 (0.06%)
▲
5d:
-2.33%
30d:
+3.23%
90d:
-28.07%
BUY
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When BWAY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: BWAY shows positive signals but monitor for confirmation. Market pricing in 15.1% decline. Moderate conviction.
💡 BUY OPPORTUNITY: BWAY shows positive signals but monitor for confirmation. Market pricing in 15.1% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$21.75
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$13.50
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BWAY is currently trading at $16.32, which is considered slightly high relative to its 30-day fair value range of $14.35 to $16.87. From a valuation perspective, the stock is trading at a discount (Forward PE: 36.5) compared to its historical average (59.7). Remarkably, the market is currently pricing in an annual earnings decline of 15.1% over the next few years. This pessimistic expectation contrasts with the company's recent 321.2% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, BWAY is in a strong downtrend. Immediate support is located at $15.35, while resistance sits at $17.35.
Market Sentiment: BWAY has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BWAY is in a strong downtrend. Immediate support is located at $15.35, while resistance sits at $17.35.
Market Sentiment: BWAY has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$14.35 -
$16.87
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
69.0%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Trading above Wall St target ($15.33)
Trading Range Analysis
30-Day Trading Range
$14.35 -
$16.87
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$15.35
Resistance Level
$17.35
Current Trend
Strong Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
36.51
Wall Street Target
$15.33
(-6.0%)
Revenue Growth (YoY)
27.4%
Earnings Growth (YoY)
321.2%
Profit Margin
14.5%
Valuation Discount vs History
-15.1% cheaper
PE vs Historical
36.5 vs 59.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-15.1%
(market-implied from PE analysis)
1-Year Target
$14.68
(-10%)
2-Year Target
$13.21
(-19%)
3-Year Target
$11.89
(-27%)
3-Yr Target (if PE normalizes)
(PE: 37→60)
$19.44
(+19%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 36.5, Growth: 45.6%)
$50.39
(+209%)
Base:
(SPY PE: 22.0, Growth: 45.6%)
$30.42
(+87%)
Bear:
(PE: 18.7, Growth: 45.6%)
$25.86
(+59%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (93x PE), but valuation improves significantly next year (37x PE) as earnings recover.
Trailing PE: 93.00 | Current EPS (TTM): $0.18
Bull Case
$36.83
(+126%)
Analyst growth 100.0%, PE expands to 102.3
Base Case
$33.48
(+105%)
Market implied 100.0%, PE stable at 93.0
Bear Case
$11.38
(-30%)
Severe decline -20.0%, PE contracts to 79.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 36.5 to 59.7
Stabilization Target:
$26.67
(+63.5%)
PE Expansion Potential:
+63.5%
Share & Embed Analysis
Last updated: May 14, 2026 4:34 PM ET
Data refreshes hourly during market hours. Next update: 5:34 PM
Data refreshes hourly during market hours. Next update: 5:34 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BWAY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 55 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$84 | 60 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 62 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 53 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 52 HOLD |
